Scholars@Duke
Michael Barry Kastan

Michael Barry Kastan

William and Jane Shingleton Distinguished Professor of Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
michael.kastan@duke.edu
MSRB3, 3 Genome Court, Box 103057, Durham, NC 27710
MSRB3, 3 Genome Court, Box 103057, Durham, NC 27710

Scholarly Works - Other

Table S5 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 17, 2026 <p>Clonogenic survival treated with ATMi, DNA-PKi, the combination and XRD-0394</p> ... Full text Cite

Table S1 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 17, 2026 <p>Clonogenic survival treated with ATMi and DNA-PKi and combination</p> ... Full text Cite

Data from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <div>Abstract<p>A majority of patients with cancer receive radiotherapy as part of their treatment regimens whether using external beam therapy or locally-delivered radioisotopes. While often effective, some tumors are inadequately cont ... Full text Cite

Table S5 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <p>Clonogenic survival treated with ATMi, DNA-PKi, the combination and XRD-0394</p> ... Full text Cite

Data from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <div>Abstract<p>A majority of patients with cancer receive radiotherapy as part of their treatment regimens whether using external beam therapy or locally-delivered radioisotopes. While often effective, some tumors are inadequately cont ... Full text Cite

Table S1 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <p>Clonogenic survival treated with ATMi and DNA-PKi and combination</p> ... Full text Cite

Table S1 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <p>Clonogenic survival treated with ATMi and DNA-PKi and combination</p> ... Full text Cite

Table S5 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Other · June 4, 2024 <p>Clonogenic survival treated with ATMi, DNA-PKi, the combination and XRD-0394</p> ... Full text Cite